Methods and Apparatus for Phototherapy - Patent application
An implantable phototherapy device addresses the challenge of shallow light penetration by wirelessly delivering light therapy with controlled intensity and temperature monitoring, effectively treating deep tissues and activating therapeutic agents for improved medical outcomes.
Patent Information
- Application Number
- JP2022523395
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-10-21
- Filing Date
- 2020-10-21
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2040-10-21
AI Technical Summary
Light therapy for medical treatments is limited by the shallow penetration depth of visible and near-infrared wavelengths within the body, making it difficult to reach targeted treatment areas such as tumors or neuronal tissues at depths of 10-25 cm without adjacent implanted light sources.
An implantable phototherapy device with a power receiver element, light delivery element, and tether, capable of wirelessly receiving power and delivering light therapy to target areas, equipped with features like expandable members, temperature sensors, and independently controllable light sources to ensure thorough illumination and safety.
The device effectively delivers light therapy to deep tissues, activating therapeutic agents and providing localized treatment, while minimizing tissue damage through temperature monitoring and controlled light intensity, enhancing treatment efficacy for conditions like brain cancer.
Smart Images

Figure 0007591833000001 
Figure 0007591833000002 
Figure 0007591833000003
Abstract
Description
[Technical field]
[0001] (Priority Claim) This application claims the benefit of U.S. Provisional Patent Application No. 62 / 923,738, filed October 21, 2019, the entire contents of which are incorporated herein by reference. [Background technology]
[0002] Light delivery as therapy is an essential part of human survival. Light from the sun regulates circadian rhythms and produces vital vitamin D in the skin throughout the day. Light is used in the form of therapy to treat eye and skin conditions, or to reduce bilirubin levels and treat neonatal jaundice. Light delivery can be used to treat several other conditions. Summary of the Invention [Means for solving the problem]
[0003] In the drawings, which are not necessarily drawn to scale, like numbers may describe similar components in different figures. Like numbers with different letter suffixes may represent different instances of similar components. The drawings illustrate generally, by way of example, but not by way of limitation, various embodiments discussed in the present document. The present invention provides, for example, the following: (Item 1) 1. An implantable phototherapy device, comprising: a receiver element configured to receive power from an external power transmitter; a light delivery element configured to be powered by the power provided by the power receiver and to deliver light therapy to a target treatment area; a tether element operably coupled to the light delivering element and the receiver element; Equipped with The device, wherein the tether element is configured to deliver the power from the receiver element to the light delivering element. (Item 2) Item 1 , the device of item 1 , wherein the receiver element comprises a coil configured to receive the power from the external power transmitter, the power comprising radio frequency energy. (Item 3) Item 1, the device comprising: a sealed housing operably coupled to the tether; and an electronic component disposed within the sealed housing, the electronic component configured to control the power delivered to the light delivering element. (Item 4) Item 1, the device of item 1, wherein the light delivery element comprises a light source encapsulated within an optical material, the optical material configured to protect the light source, and the optical material facilitating the transmission of light from the light delivery element to the target treatment area. (Item 5) Item 1, the device of item 1 further comprising an optical light guide coupled to the light delivery element, the optical light guide shaped to facilitate delivery of light from the light delivery element to the target treatment area. (Item 6) Item 1, the device of item 1, wherein the light delivery element comprises a plurality of light sources disposed on a substrate, the substrate being configured to be shaped to conform to the target treatment area. (Item 7) 7. The device of claim 6, wherein the substrate is a light guide configured to direct light to the target treatment area, and the substrate is configured to be trimmed to a desired shape to fit the target treatment area. (Item 8) Item 1, the device comprising: a plurality of light sources configured to be independently controllable with respect to one another. (Item 9) Item 10. The device of item 1, wherein the light delivery element further comprises a temperature sensor configured to measure a temperature at the target treatment area. (Item 10) 2. The device of claim 1, wherein the light delivery element is disposed within a radially expandable member having an expanded configuration and a collapsed configuration, wherein in the expanded configuration, the radially expandable member conforms to the target treatment area. (Item 11) Item 1, the light delivery element further comprising a port configured to releasably receive an optical fiber optically coupled to an external light source, wherein light from the external light source is delivered via the optical fiber to the light delivery element for illumination of the target treatment area. (Item 12) 1. A phototherapy system, comprising: An implantable phototherapy device according to item 1; an external power transmitter configured to wirelessly transmit the power to the receiver element; The system comprises: (Item 13) Item 13. The system of item 12, further comprising a planar immersion lens disposed between the external power transmitter and the receiver element, the planar immersion lens configured to focus energy from the external power transmitter towards the receiver element. (Item 14) 13. The system of claim 12, further comprising an electrode configured to provide electrical stimulation to the target treatment area. (Item 15) 13. The system of claim 12, further comprising at least one support element, the support element configured to align with and support tissue in the target treatment area. (Item 16) Item 13. The system of item 12, further comprising a photosensitizer. (Item 17) 1. A method of delivering phototherapy to a target treatment area within a patient, the method comprising: providing an implantable phototherapy device comprising a receiver element, a light delivery element, and a tether element; implanting the phototherapy device within the patient at the target treatment area; wirelessly transmitting power from an external power transmitter to the power receiver element; transmitting the power from the receiver element to the light delivering element via the tether; illuminating the target treatment area with light from the light delivery element; A method comprising: (Item 18) 20. The method of claim 17, wherein wirelessly transmitting the power from the external power transmitter to the receiver element includes receiving radio frequency energy with a coil. (Item 19) 20. The method of claim 17, wherein the illuminating comprises illuminating the target treatment area with a plurality of light emitting elements that are independently controllable. (Item 20) Item 18. The method of item 17, wherein wirelessly transmitting the power includes transmitting the power from the external power transmitter and focusing the power toward the receiver element using a planar immersion lens. (Item 21) 20. The method of claim 17, further comprising electrically stimulating tissue in the target treatment area with energy provided by an electrode adjacent to the light delivery element. (Item 22) 18. The method of claim 17, wherein the target therapeutic area comprises the patient's brain. (Item 23) releasably coupling an optical fiber to the light delivering element; inputting light from an external light source through the optical fiber into the light delivering element; illuminating the target tissue with the light from the external light source; 18. The method of claim 17, further comprising: (Item 24) Item 18. The method of item 17, wherein the light delivery element comprises a plurality of light sources disposed on a substrate, the method further comprising shaping the substrate to conform to the target treatment area and directing light in a plurality of directions to illuminate the target treatment area. (Item 25) 25. The method of claim 24, further comprising trimming the substrate to a desired size or shape to fit the target treatment area. (Item 26) 20. The method of claim 17, further comprising measuring the temperature in the target treatment area with a temperature sensor. (Item 27) Item 18. The method of item 17, wherein the light delivery element comprises a plurality of light sources encapsulated within an optical material, the optical material being a light guide that directs light from the plurality of light sources to the target treatment area. (Item 28) Item 18. The method of item 17, wherein the light delivery element is disposed within a radially expandable member, the method further comprising radially expanding the radially expandable member to align with and conform to the target treatment area. (Item 29) 20. The method of claim 17, further comprising positioning a support element within the target treatment area to support tissue within the target treatment area and help ensure that the tissue is illuminated. [Brief description of the drawings]
[0004] [Figure 1] FIG. 1 illustrates an optical illumination system.
[0005] [Diagram 2] FIG. 2 illustrates a light illumination system coupled to a patient's head.
[0006] [Diagram 3] FIG. 3 illustrates a light illumination system coupled to a patient's head.
[0007] [Figure 4] FIG. 4 shows some examples of electronic components within the housing.
[0008] [Diagram 5] FIG. 5 illustrates some examples of lighting elements.
[0009] [Figure 6] 6A-6D show example optical guide geometries.
[0010] [Figure 7] FIG. 7 shows one example of lighting elements disposed on a customizable substrate.
[0011] [Figure 8] FIG. 8 shows another example of the shape of the optical guide.
[0012] [Figure 9] 9A-9D show examples of customized light guides that can be coupled to lighting elements.
[0013] [Figure 10] FIG. 10 shows another example of a lighting element.
[0014] [Figure 11] FIG. 11 illustrates the use of a planar immersion lens.
[0015] [Figure 12] FIG. 12 illustrates the use of multiple light sources in a lighting system.
[0016] [Figure 13] FIG. 13 shows an example of light source control.
[0017] [Figure 14] FIG. 14 illustrates one example of an illumination system that may also include electrical stimulation to the targeted treatment area.
[0018] [Figure 15A] FIG. 15A illustrates one example of a reinforced substrate.
[0019] [Figure 15B] FIG. 15B shows the reinforced substrate of FIG. 15A placed within a tumor cavity.
[0020] [Figure 16] FIG. 16 shows another example of a reinforced substrate.
[0021] [Figure 17] FIG. 17 illustrates the use of additional support elements within the tumor cavity.
[0022] [Figure 18] FIG. 18 illustrates another example of an additional support element within a tumor cavity.
[0023] [Figure 19] FIG. 19 illustrates a second port for coupling an external light source to the lighting element.
[0024] [Figure 20] 20A-20B illustrate the use of multiple light sources within a lighting element and the resulting lighting pattern.
[0025] [Figure 21] FIG. 21 illustrates an example of a method for treating a tumor. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0026] Light delivery as therapy is an essential part of human survival. Light from the sun regulates circadian rhythms and produces vital Vitamin D in the skin throughout the day. Light is used in the form of therapy to treat eye and skin conditions, or to lower bilirubin levels and treat neonatal jaundice. More recently, light has been seen as a potential source for new therapies paired with light-activated drugs, leading to new advances not only for skin cancer, but also for some internal tumors and other conditions.
[0027] The main challenge of using light to treat medical diseases is that light does not travel very far in the body. Light is absorbed by skin and tissue, which limits the penetration depth of visible and near-infrared (NIR) wavelengths to 3-5 millimeters. Applying phototherapy to tumors or stimulating neurons to treat movement disorders may require light at depths of 10-25 cm, shallower, or even deeper, and an implanted light source adjacent to the target treatment area is the only practical way for light to reach such depths in the human body.
[0028] This disclosure describes novel powering, light delivery, and integration aspects of implantable phototherapy devices, systems, and methods of use. Implants can be designed to deliver a single therapy and / or can be integrated with other forms of stimulation and / or therapeutic agents other than light, and in so doing, deliver innovative combination therapies. Implants can also be modified to include sensing features, such as for modulating therapeutic drug dosage in response to the patient's physiological state.
[0029] FIG. 1 illustrates one example of a light illumination system 100 that can be used to deliver light therapy inside a patient's body, for example, in the treatment of tumors deep within the body, such as glioblastoma in the brain. Although the examples disclosed herein are primarily directed to implantation of the device in the brain as a treatment for brain cancer, this is not intended to be limiting, and one skilled in the art will understand that the device can be implanted in any other part of the body to deliver light therapy inside the body as part of a treatment for other medical conditions. Thus, the devices and systems described herein can be surgically implanted in a tumor cavity created by resection of a tumor, or they can be placed in a natural body cavity or natural tissue adjacent to the affected area without surgical modification (e.g., by implantation directly into tissue). In either situation, the light can be used to activate various therapeutic drugs that help fight the tumor or provide other therapeutic effects to treat the disease, thereby providing localized therapy. For example, in photodynamic therapy, light can be used to activate a therapeutic agent (also called a photosensitizer) that is absorbed by cells, resulting in the production of reactive oxygen species (ROS), which are toxic to host cells and lead to cell death in tumors and the like, which is well documented in the patent and scientific literature. ROS production can be quantified by titration methods known in the art. The wavelength of light must overlap with the activation spectrum of the photosensitizer.
[0030] The lighting system includes a receiver element, which may include a wireless coil 101 and a housing 200. The system may also include a tether wire 300 and a light source (also referred to as a light element or lighting element, or light source) 400.
[0031] The receiver element in this or any example may or may not include any energy storage device (e.g., a battery, capacitor, or other storage element). If no storage device is present, therapy is provided only when the external power source is activated. If an energy storage device is included, the device may be turned on as needed and the lighting element is powered by the energy storage device. The wireless coil 101 is configured to receive radio frequency energy from an external transmitter coil in an external power source and may have one or more turns of conductive wire coated with insulation. The turns may take any geometric shape, such as a circular or helical coil, and the coil may be made of any material that is conductive to electromagnetic energy. The wireless coil may optionally be made of a printed circuit board or a flexible printed circuit board with metal or conductive traces in a circular or other coil pattern. The coil is sized for wireless power transmission through tissue, such as through the patient's scalp at any depth, such as less than about 5 cm, 4 cm, 3 cm, 2 cm, or 1 cm deep, and the coil can tolerate variations in intervening tissue thickness. The wireless transmitter and receiver can optionally be capable of two-way authentication, such that only approved devices can cooperate and transmit power to the implanted device. Optionally, secure encryption techniques can be used to ensure that the device cannot be activated by an unauthorized user or transmitter.
[0032] The wireless coil 101 may be electrically and mechanically coupled to an optional housing 200, and energy captured by the coil 101 is delivered to the housing 200, which contains various electronic components for managing the power and controlling the duty cycle of the light source 400. The electronics within the housing may be mounted on a printed circuit board.
[0033] The housing may be of any size or shape and may be formed from any number of materials, such as titanium, or any material that is biocompatible. Wires from coil 101 or tether 300 may be coupled to the housing via ceramic feedthroughs. Additional disclosure regarding the electronic components within housing 200 is provided hereinafter.
[0034] The tether wire 300 is operatively coupled to both the housing 200, the electronics within the housing 200, and the light source 400. The tether can be formed of any material that is conductive and with adequate strength to tether and ensure that the light source 400 remains coupled to the housing. The tether wire can be soldered to an electronic feedthrough in a hermetically sealed housing (sometimes also referred to as a "can") that encloses the power electronics. The tether 300 can be several wires that run linearly between the housing and the lighting element, or the wires can be coiled, helically wound, braided, twisted together, or of any configuration, and the wires can be of sufficient length to ensure that the housing can be anchored in one position and the light source can be placed where desired. The tether can include multiple electrical wires passing through multi-lumen tubing resulting in a single filament, or the tether can have two or more filaments.
[0035] Light source 400 may be a single light source or may include multiple light sources. For example, multiple light sources may be included within the light source, which may be configured to be adjusted to various intensities, all having the same or different wavelengths of light, which may be controlled together or independently of one another. The wavelengths may be selected to maximize photoactivation of the therapeutic agent.
[0036] FIG. 2 shows the phototherapy system of FIG. 1 coupled to a patient's skull 1000. Here, the phototherapy system includes a receiver element having a coil 101 for receiving RF energy from an external power source and a housing 200 containing electronic components for controlling the device. A tether 300 operably couples the housing to an illumination element that is placed in a tissue cavity in the patient's brain after tumor resection. The illumination element is not visible in this view. The tether may be coiled (301) along any portion of its length to take up excess slack or to provide strain relief. In this example, the receiver element is attached to the patient's skull using techniques known in the art (with sutures, staples, adhesives, etc., or with fasteners such as screws, etc.) such that the receiver element is positioned under the scalp. The tether is also positioned between the scalp and the skull. A burr hole may be drilled through the skull to allow the tether and lighting element to be threaded through the skull and into the tissue cavity, where the lighting element may be attached to the tissue where it will illuminate the target treatment tissue and may be left behind after resection or may be anchored in a desired location where it will provide therapy such as activating a drug to reduce or eliminate tumor cells that may recur. The burr hole may be the same as the burr hole used to provide access to the surgeon during tumor resection or it may be a separate burr hole. In this example, the receiver element may be placed behind the ear as shown or the receiver may be placed anywhere along the skull.
[0037] Optionally, fasteners (not shown), such as clips or grommets, may be used to help protect the tether as it passes through openings in the skull that may have sharp edges. The fasteners help hold the tether in place so it cannot be pulled out and provide cable management to prevent tether tangling. The fasteners may be made of any biocompatible material, such as polymers, silicones, metals, etc.
[0038] FIG. 3 shows the phototherapy system of FIG. 1 in addition to an external power source 700 that wirelessly provides radio frequency power to the phototherapy system. The phototherapy system includes a power source 700, here a receiver element including a coil 101 for receiving radio frequency (RF) energy from an RF wireless transmitter. The receiver element also includes a housing 200 that includes electronic components for controlling the phototherapy system. Fasteners 201, such as screws, may be used to secure the housing to the skull 1000 below the scalp. A tether 300 electrically couples the housing and the electronic components within the housing to an illumination element (not visible) that is placed within a cavity in the brain tissue that is formed after the tumor is resected. A bone plate 500 may be repositioned within the burr hole to aid in closing the skull, and an eyelet 510 or clip may be used to help secure the tether to the skull and prevent damaging the tether. The tether may be coiled or non-coiled. Here, the receiver element is positioned on the side of the patient's head, at about eye level.
[0039] FIG. 4 illustrates an example of a housing 200 that may be used with any of the examples of the phototherapy system disclosed herein. Some of the electronic components that may be located within the housing to help control the phototherapy system include a rectifier, such as a full-wave bridge rectifier 210 with four diodes arranged to convert alternating current (AC) received from the coil 101 to direct current (DC). A DC / DC converter 220 is coupled to the rectifier and may convert power or voltage levels from one level to another, which is operably coupled to a lighting driver 240 that drives lighting elements (not shown), which may be one or more light sources, such as light emitting diodes. A microcontroller 230 may also be included within the housing and control the system. An impedance matching network 102 may couple the coil to the rectifier to ensure maximum power transfer and minimize losses. The impedance matching network may include a capacitor or may have active electronics to tune the resonance. The housing may also include a temperature measurement component 250 that monitors the temperature from a sensor placed at the target treatment site (not shown), thereby helping to ensure that the temperature at the light source is not excessive and does not cause tissue damage. The temperature measurement component 250 may also monitor the temperature of the receiver electronics to ensure that overheating is avoided. The housing may be formed from any biocompatible material, such as titanium, and provide a hermetic seal for the electronic components. The housing may act as a heat dissipation element, or a separate heat dissipation element (not shown) may also be included within the housing. Electrical leads exiting the housing form a tether 300 that is coupled to the illumination source.
[0040] FIG. 5 shows an example of a lighting element 400 that can be coupled to the tether 300 and used within any example of a lighting system. The tether allows power to be delivered to the lighting element from the power receiver element and optionally electrically couples an optional temperature sensor to the electronics within the housing. The tether also provides a mechanical coupling between the lighting element 400 and the power receiver element so that the two remain coupled together. Here, the lighting element 400 includes one or more flexible substrates 430, such as flexible printed circuit boards (PCBs), that can be molded into any desired configuration to conform to the target treatment area. Polyimide is an example of a suitable PCB material. The target treatment area may be a cavity in the brain created after a tumor is removed, and therefore the substrate should be formable into a three-dimensional shape. Additionally, the flexible substrate, once formed, may help support the tissue surrounding the cavity and prevent tissue from collapsing inwards, which may prevent some of the tissue from being illuminated. Here, multiple lighting elements 420 are bonded to a flexible substrate, which is bent into an upside-down rectangular U-shaped configuration (or a staple with two vertical legs and one horizontal bar connecting the legs), with one lighting element 420 on each leg of the U-shape and one lighting element on the horizontal connection between the legs of the U-shape. This ensures that the light emitted from the lighting elements will be uniformly distributed radially outward in several different directions to illuminate the target treatment area. The lighting elements 420 can be one or more LEDs that can be controlled independently of each other or controlled together. The LEDs can emit a single wavelength of light or several wavelengths of light, and their intensity can also be adjusted as well as the duty cycle of the time they are on and the time they are off. The PCB can contain other electronic components that help control the light and automatically direct the power from the tether to each LED continuously in the desired cycle. This allows the light intensity to be increased or decreased as needed to control the illumination of different areas of the tumor cavity. As the LED cycles, more intense light exposure is followed by periods of darkness, which may allow oxygen in the tissue time to recover between cycles of illumination when the cavity is dark, while increasing activation of the photosensitizer.The light source and substrate may be encapsulated (410) in a material that not only protects the device but also acts as a light guide to help deliver light to the target treatment area. For example, the encapsulation 410 may be formed from silicone or another translucent material that acts as a light guide for delivering light, or the encapsulation may help to diffuse the light. The encapsulation material may be any shape, including a flat planar sheet, a square box, a rectangular box, rounded shapes, cylinders, spheres, ovals, etc., and is selected to fit the tumor cavity.
[0041] Because light can generate heat and overheating can undesirably damage tissue, an optional temperature sensor 251, such as a thermistor, can also be coupled to the flexible substrate to allow for temperature monitoring in the treatment area. If excessive heat is generated, the light can be turned off. As mentioned above, the lighting element 420 and temperature sensor 251 can be optionally encapsulated in a material that protects the light and sensor and provides desirable optical properties for delivering light from the lighting element to the target treatment area. For example, the encapsulating material can be optically transparent, or it can include a diffusing or reflective material (not shown), such as titanium dioxide particles. The encapsulating material can then also act as a light guide or wave guide, ensuring minimal light loss during transmission. The encapsulating material can have a primary layer for light protection and to help dissipate heat. An optional secondary layer of encapsulating material can be provided that acts as a light guide and facilitates distribution of light to the target treatment area. Several examples of layers of encapsulation are disclosed herein, any of which may be used with any of the examples of lighting elements.
[0042] 6A-6D show examples of optical light guide shapes that can be used with any of the illumination elements disclosed herein. The light guide can be integral with the encapsulation material surrounding the light source, or the light guide can be disposed on top of the encapsulation material. The light guide can be formed from the same material as the encapsulation layer, or a different material can be used. The shape of the optical light guide helps distribute the light to the target treatment area with minimal light loss, is shaped to fit within the cavity left after tumor resection, and ensures that all tissue in the target treatment area is illuminated, thereby activating the therapeutic agent. In addition, the optical light guide can help physically or mechanically support the tissue and prevent it from collapsing, which also helps ensure that all tissue in the target treatment area is illuminated.
[0043] 6A shows a cloud-shaped optical light guide 451. The cloud shape may include a number of lobes extending radially outward. A light source and a temperature sensor may be disposed within the cloud.
[0044] 6B shows an optical light guide that includes a central spherical ball 453 with spokes extending radially outward. The spokes may be linear spokes or take any other shape and may help to anchor the optical light guide in tissue and support the tissue and direct the light to the target treatment area. A light source and a temperature sensor may be disposed within the optical light guide.
[0045] 6C illustrates a star-polygon optical light guide 452. The star may include multiple arms extending radially outward, each of which may taper radially outward and terminate in a narrow tip. A light source and a temperature sensor may be disposed within the star.
[0046] 6D shows an eye-shaped optical light guide 454. The optical light guide may have a wide arcuate middle portion with both sides tapering to a narrower portion. A light source and a temperature sensor may be disposed within the optical light guide.
[0047] FIG. 7 shows one example of an illumination element having multiple light sources, here LEDs 420, disposed on a substrate 430 such as a flexible PCB. The illumination element is coupled to a tether 300 such that it can receive power from a power receiver element and an optional temperature sensor (not shown) can be operatively coupled to electronic components within the housing. The illumination element can be coupled to a flat planar sheet of material or wallpaper 455, which can be formed from an optical material that can act as a light guide and help distribute the light to the target treatment area. The wallpaper can also be referred to as a conformable stretchable cavity paper (CTCP) encapsulation. The flat planar material can be bent and trimmed / cut to size to conform to and be secured to the target treatment area. The entire flat planar material can be trimmable or only a section can be trimmable. Areas that should not be trimmed are clearly marked (e.g., adjacent to the LEDs). The flat planar material may then be bonded to the tissue in the cavity left after tumor resection, such as with adhesives, sutures, friction fit, or other techniques known in the art. If adhesives are used, light, such as ultraviolet light (UV), may be introduced into the wallpaper and distributed by the wallpaper to the target treatment area to help cure the adhesive, such as cyanoacrylate. Light may be provided by an external light source, as will be discussed below.
[0048] Wallpapers may be desirable because surgical cavity dynamics and its impact after resection of brain metastatic cancer are known to be a challenge for postoperative radiosurgery in patients with glioblastoma multiforme (GBM). Patients with symptomatic brain metastatic cancer are typically treated with a surgical resection procedure followed by postoperative stereotactic radiosurgery to the surgical cavity for improved local control. Currently, there is no clear consensus on the timing or start date of radiation therapy simulation for these patients based on a large number of brain metastatic cancer experts. As an illustrative example of the challenges faced today, some have opined that there appears to be a theoretical advantage of delayed radiation therapy (4-6 weeks postoperatively) in response to known surgical cavity collapse, which could reduce the target volume.
[0049] There are numerous studies documenting retrospectively assessed changes in surgical cavities in patients treated with surgery and postoperative radiation therapy. There was substantial cavity collapse (>2 cm) at a mean of 24 days postoperatively in this cohort. 3 The rate of CT scans appears to be in the range of 21-31%. Some caregivers have therefore concluded that delaying radiation therapy for more than two weeks after surgery does not provide the benefit of a smaller target volume. What appears to be clear is that a significant portion of the surgical cavity changes volume substantially during the period including 3-4 weeks after surgery for a range of reasons including edema control, healing, fibrosis, etc. This has been evaluated to provide an opportunity to reduce treatment volume by delaying radiation after surgery.
[0050] However, delays in treatment would have a devastating impact on these at-risk patients. There remains a need to maximize the light coverage of the surgical cavity edge that endures throughout the treatment cycle in light of known cavity dynamics and cavity collapse. The combination of light sources embedded within the CTCP capsule ensures that the cavity edge surface does not otherwise escape illumination.
[0051] Such CTCP capsules may comprise a multi-material matrix that will be used to paper the interior edges of the excised cavities with light. The multi-material matrix includes various materials, each with specific properties to maximize the conformal papering effect and, in some cases, to act as a waveguide. The matrix base material may be a flexible biocompatible material that uniformly conforms to the shape of the cavity edge but does not impede the transmission or fluence of light. The matrix acts as a scaffold for various standard or custom elements, including a range of higher tensile strength materials to maximize the expansion effect of the CTCP capsule. Such expansion properties will counter the tendency of the cavity to collapse, thus ensuring uniform, consistent, and personalized distribution of light activation and light steering. In some cases, the scaffolding function of the base matrix is not limited to only elements to counter cavity collapse. In some cases, the multi-material matrix may include elements that scaffold or anchor the optical elements themselves to optimize the placement of various optical components and system performance. Such capsules may be personalized. In some instances, the higher extension spans function as one or more staves. Each stave can be individually controlled to optimize the papering. The multi-material matrix can be molded or impregnated with the polymeric material to be optimized. In some cases, the higher tensile strength material can be embedded within the matrix substrate or protrude from it into one or more spans of cavity-spanning material. In some cases, the cavity-spanning material may or may not anchor or suspend one or more light elements or multiple light systems. Such customization can occur at the time of implantation or can function as a modular surgical kit. Such instances can include various multi-material matrices of various shapes, sizes, and configurations. Some CTCP capsules can include one or more radioactive markers to aid in visualization, for example, employing CT and / or MR scanning. Such an approach would aid in distinguishing the capsule from surrounding tissue, tumor tissue, and allow for determination of wallpaper and / or lighting element movement or separation.
[0052] Since surgical cavities are known to collapse or shrink, some resection cavities may also have bends and difficult to reach pockets. Such custom CTCP capsules may be personalized to combat such tricky cavity conditions and dynamics. Various adhesives, gels, fibrous meshes, and wave guides may also be employed to optimize the CTCP capsule. Light sources may be embedded within the CTCP. CTCP material may be overmolded onto the LED and printed circuit board. The capsule may be closed, partially encapsulated, or a modular combination of various capsule elements and / or may include one or more pre-configured openings.
[0053] The multi-material matrix may be a combination of multiple different materials and / or one or more material thicknesses. The multi-material matrix may be multiple different materials that are configured to be expandable to function as an implantable balloon, as will be described in more detail below. The CTCP paper-applying kit may include a pre-configured assembly of various components designed to allow the caregiver to optimize the CTCP capsule according to the patient's needs.
[0054] FIG. 8 shows another example of a light guide that may be integral with or coupled to an illumination element. Here, the illumination element includes one or more light sources 420, such as LEDs, mounted on a flexible or rigid PCB substrate 430. The LEDs are powered via a tether 300. The light guide 456 may include a spherical center section with multiple spokes extending radially outward, or the light guide 456 may include a flat planar rounded center section with multiple planar spokes extending radially outward. The spokes are formed from an optical material that helps deliver light into the target treatment area with minimal light loss, and the spokes also help support tissue within the cavity formed after tumor resection, thereby preventing the cavity from collapsing. This helps ensure illumination of the target treatment area. The spokes may be any shape, including flat planar rectangular arms, rounded cylindrical arms, or any other shape.
[0055] 9A-9D show examples of customized light guides that can be coupled to lighting elements.
[0056] In FIG. 9A, a tether 300 delivers power to a light source encapsulated in a standard shape 401, such as a sphere or square. The light source is embedded in a cavity 1100 formed after resection of a tumor from the brain in a patient's skull 1000. In some circumstances, it may be beneficial to provide an additional light guide element that can be customized to any shape and easily bonded to the encapsulation to help support the tissue in the cavity 1100 and facilitate delivery of light to the target treatment area. In FIG. 9A, an outer light guide 460, customized to fit the cavity, is bonded to the lighting element to form an outer ovoid light guide. The outer light guide may be snap-fitted into engagement with, adhesively bonded to, or otherwise bonded to the inner primary light element.
[0057] 9B-9D show examples of light guides that can be snapped onto, bonded to, or otherwise coupled to a light element.
[0058] 9B, spherical light guide 461 has a smaller hemispherically shaped recessed area sized to receive the light element. The light element is inserted into the recessed area and then adhesively bonded or snapped into place. In this example, the light element is coupled off-center to light guide 461, however, the light element could also be positioned in the center of the spherical light guide.
[0059] 9C shows a cloud-shaped light guide 462 having a hemispherical recessed area sized to receive a light element. The light element is inserted into the recessed area and then adhesively bonded or snapped into place. The cloud-shaped light guide may include a number of lobes extending radially outward.
[0060] 9D shows a rectangular shaped light guide 463 with linear sides and an arched or wavy top and bottom. The light guide includes a hemispherical shaped recessed area sized to receive a light element. The light element is inserted into the recessed area and then adhesively bonded or snapped into place.
[0061] Those skilled in the art will appreciate that the examples of Figures 9A-9D are not intended to be limiting and that light guides of any shape may be coupled to illumination elements to support tissue within the tumor cavity and ensure that light is delivered to the targeted treatment area.
[0062] FIG. 10 shows another example of an illumination element that can be used to conform to the tumor cavity 1100 after the tumor has been resected. Here, an illumination element with an encapsulation 401 having any of the configurations described herein is coupled to a tether 300 and powered by power therefrom. The illumination element in the encapsulation 401 can include one or more light sources coupled to a substrate such as a flexible or rigid PCB. The illumination element is coupled to an expandable member 470 such as a balloon instead of the solid encapsulation material previously described above. The expandable member is compliant, so as it is radially expanded, it will conform to the walls of the tumor cavity and provide uniform support, thereby helping to ensure that the target treatment area is illuminated with light. In addition, the radially expandable member can be adjusted, either by further expansion or by collapsing it, to accommodate changes within the tumor cavity. The expandable member can be expanded with a fluid such as a liquid or gas. A contrast agent can also be used so that the balloon can be visualized with x-ray imaging.
[0063] FIG. 11 illustrates the use of a planar immersion lens 600 that may be disposed on a substrate. The planar immersion lens 600 may be disposed between an external power source (not shown) and a receiver element 700 in the illumination system, and serves to focus the energy onto the receiver for efficient transmission of the energy. The substrate may be rigid or flexible and may be disposed adjacent to the skull 1000 or may be attached in the vicinity of the skull 1000 and the receiver element. Here, the illumination system includes a wireless receiver 700, which may be any of the examples disclosed herein, either disposed within the tumor cavity after the tumor is resected or attached to the skull 1000. The wireless receiver 700 includes an antenna coil 710 for receiving energy from an external energy source, which is focused onto the coil by the immersion lens. The illumination element, which may include one or more light sources such as LEDs, is powered by the power delivered to the coil. The light source may be encapsulated within an encapsulating material 720, which helps to diffuse the light and also helps to hold the implant in place within the tumor cavity 1100. Any of the encapsulating materials and light guides disclosed herein may be used with this example of an illumination system.
[0064] FIG. 12 illustrates the use of multiple light sources in a lighting system. Here, the lighting element includes multiple light sources 420 oriented to provide directional light output. In this example, three light sources 420, such as LEDs, are oriented so that light is emitted radially outward and in different directions relative to adjacent light sources. Here, light is emitted in the 3:00 o'clock direction, the 6:00 o'clock direction, and the 9:00 o'clock direction. A tether 300 delivers power to the light sources. The lighting elements are placed in a tumor cavity 1100 formed after resection of a tumor from the brain in a patient's skull 1000. The lights are independently controllable to steer the light, and also to adjust the light intensity and on / off timing independently. Some electronics 480 may be placed on a substrate 430 that holds the light sources 420. The substrate 430 may be a printed circuit board. The lighting elements may be encapsulated 410 in an optical material, which may be It facilitates light delivery by diffusing the light or helping to transmit the light efficiently, as well as by providing a protective cover for the light source. Any of the encapsulants or light guides described herein can be used as the encapsulant. Having multiple lights allows for a variety of light therapies to be provided.
[0065] FIG. 13 shows an example of a light source control 480 that can be used with any example of the lighting system described herein, such as in FIG. 12. The light source control 480 controls the illumination of the target tissue when multiple light sources are used, allowing independent control of the light sources. The control 480 includes an oscillator 481 and a multiplexer 482 that cycles through each of the four LEDs 483 shown in FIG. 13 at a desired switching frequency. In an alternative example, a microcontroller 484 can control the oscillator 481 and the multiplexer 482. A tether 300 connects the control with the power receiver element. Electrical components can be mounted on the PCB 430. The control 480 can also be in the housing instead of the lighting element.
[0066] FIG. 14 illustrates an example of an illumination system that may also include electrical stimulation to the target treatment area. Here, an illumination system is placed in the tumor cavity 1100 after the tumor has been resected from the brain in the patient's skull 1000. The illumination system may be any of the systems disclosed herein and may include a tether 300 for providing power to the illumination element 420, which may have one or more light sources coupled to a substrate, such as a PCB 430. The light sources and substrate may be encapsulated (410) in a material that not only protects the device but also facilitates delivery of light to the target treatment area, such as by acting as a light guide or diffusing the light. The encapsulation may be any of the example encapsulation or light guides disclosed herein and may also help to anchor the device in the tumor cavity. Conductors 801 extend from the PCB and are attached to electrodes 800 that are exposed on the sides of the light elements and can provide electrical stimulation (deep brain stimulation) to the target treatment area by direct contact with brain tissue or by conduction through interstitial fluid in the resected cavity. Thus, light therapy and electrical stimulation can be provided simultaneously. Illumination systems such as that of FIG. 14 can be used to provide deep brain stimulation in patients suffering from neurodegenerative diseases such as Parkinson's disease, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, or any other condition in which neurostimulation is beneficial. Stimulation can be provided alone or in combination with light therapy, such as by activating photosensitizers, which can be used to treat diseases including, but not limited to, brain cancer. Electrodes for tissue stimulation, whether in the brain or elsewhere in the body, can be used with any of the examples of light therapy systems described herein. In addition, phototherapy systems with electrodes are not limited to implantation within the tumor cavity formed after tumor resection, but may be placed within any tissue to which phototherapy and / or electrical stimulation is to be delivered to treat any disease or condition.
[0067] FIG. 15A shows an example of a reinforced substrate that can be used with any of the examples of light and / or electrical stimulation systems disclosed herein. For any substrates used within these examples, such as the substrate on which the light source is mounted or the light guide substrate, it may be advantageous to use a substrate with reinforcements within the substrate to provide a stiffer substrate or a substrate that can bend, flex, or otherwise molded to conform to the target treatment area and retain its shape. Here, the substrate is similar to substrate 455 of FIG. 7, a flat planar substrate that can be trimmed to a desired size and shape to conform to the target treatment area. The substrate can be formed from a material that has stiffening features, or stiffening features can be built into the substrate. For example, here, a two-dimensional grid of ribs 457 can be formed into the substrate to provide the desired stiffening properties. This helps the substrate maintain its shape when placed within the tumor cavity created after tumor resection. Illumination elements 430 (which may be any of those disclosed herein) may be positioned anywhere along the substrate, and tethers 300 are coupled to illumination elements 430 for the supply of power. The stiffening features may be formed from different materials (e.g., different polymers) having different mechanical properties (e.g., Young's modulus, durometer, etc.) compared to the base substrate.
[0068] FIG 15B shows the device of FIG 15A with stiffening features in a substrate that is implanted in a tumor cavity 1100 in the skull 1000. A tether 300 provides power to an illumination element (not shown in this figure) that is coupled to the substrate with stiffening or reinforcing members. The substrate is formed into a partially closed loop if two-dimensional, or a partially closed spheroid if three-dimensional, to support and conform to the tissue and illuminate the tissue. The substrate acts as a light guide to help illuminate the target treatment area.
[0069] FIG. 16 shows another example of a reinforced substrate such as that of FIG. 15A formed into a closed loop if in two dimensions, or a closed spheroid if in three dimensions. Here, power is delivered via tether 300 to an illumination element (not shown, but which may be any illumination element disclosed herein) that is placed on the reinforced substrate 458 within a tumor cavity 1100 in a skull 1000. The reinforced substrate may be the same as that shown in FIG. 15A or different, and the ends may remain juxtaposed to each other in a closed configuration due to reinforcements in the substrate maintaining the desired shape, or due to the use of adhesives. This helps to maintain the substrate in a desired configuration that supports the tumor cavity and ensures proper illumination of the target treatment area.
[0070] FIG. 17 illustrates the use of additional support elements within a tumor cavity 1100 within a patient's skull 1000. The wallpaper substrate concept described in FIGS. 7, 15A-15B, and 16 can be used with additional support elements disposed within the tumor cavity to help support tissue within the target treatment area and also to help distribute light to the target treatment area. Here, a tether 300 provides power to a lighting element, which can be any of those disclosed herein. The lighting element can be encapsulated in a material, and the combination of lighting element and encapsulation material can be bonded to a flat planar substrate 457 that is moldable and trimmable to fit the tumor cavity. The flat planar substrate 457 can be any of those described herein and can be optically transparent to ensure that light passes through it. Here, the wallpaper is formed into a partial closed loop if it is two-dimensional, and a partial sphere if it is three-dimensional. In some circumstances, it may be beneficial to provide additional support elements 459 that help support the tissue within the tumor cavity, prevent collapse, and may be formed from optical material, thereby forming a light guide that also helps distribute light to the target treatment area. The support elements may be thin, planar sheets of material that are trimmed and shaped to fit the tumor cavity, or they may be prefabricated into various desired shapes. The support elements may then be secured to the tissue within the tumor cavity using techniques known in the art, such as with sutures, adhesives, or other techniques. The additional support elements may also act as spacers between the tissue and the illumination element, or as optical devices to help deliver light to the tissue.
[0071] FIG. 18 shows another example of the use of additional support elements 490 in a tumor cavity 1100 in a patient's skull 1000. Again, a tether 300 provides power to the lighting elements, which may be any of the lighting elements disclosed herein. Multiple additional support elements 490 may be joined together (as indicated by the arrows) to form a complete closed or partially open loop (if two-dimensional), or a complete closed or partially open spheroid, if three-dimensional, that provides a rigid or semi-rigid structure that supports the tissue within the tumor cavity and prevents it from collapsing inward. Thus, customization is possible during surgery, ensuring that the light provided by the lighting elements can illuminate the entire target treatment area and that the cavity is supported. The support elements may snap together, interference fit together, adhesively bonded together, or use coupling mechanisms known in the art to form any desired shape, and may be formed from optical materials that aid in distributing light to the target treatment area.
[0072] FIG. 19 illustrates a second port for coupling an external light source with an illumination element. Here, a tether 300 connects an illumination element (not shown) disposed within a flat, planar substrate 455, as described in FIG. 7 above. The tether 300 delivers power to the illumination element, which delivers light to the target treatment area via the flat, planar substrate 455. As discussed above, the flat, planar substrate 455 can be shaped and trimmed to conform to the target treatment area, which can be adhesively bonded to tissue. In some cases, light can be used to help cure the adhesive, such as when cyanoacrylates are used. Thus, an external light source 1300 can provide the required curing light, such as ultraviolet light, via a port 1210, which can be releasably coupled to the external light source. The light is then delivered via the optical fiber 1200 to the flat, planar substrate, which then delivers the light to the target treatment area to promote curing of the adhesive. Once the substrate 455 is adhesively bonded to the tissue, the external light source can be turned off, uncoupled from the second port 1210, and removed. The port 1210 and the fiber 1200 can remain bonded to the flat planar substrate 455, or they can also be removed. Other components that can be adhesively bonded, such as the complementary support elements of FIGS. 17-18, the encapsulation surrounding the illumination element (e.g., of FIG. 5), the optical light guide shapes of FIGS. 6A-6D, and the complementary light guides of FIGS. 9A-9D, can also be adhesively bonded and cured using an external light source coupled to the light input port 1210 and delivered via the optical fiber 1200 to the flat planar substrate to illuminate and cure the adhesive. In other examples, the second light port can be used to introduce light through the substrate 455 to the target treatment area using an external light source to illuminate light-responsive biologicals, chemicals, or other agents.
[0073] 20A-20B illustrate the use of multiple light sources within a lighting element and the resulting lighting pattern that provides desirable control of the lighting.
[0074] A uniform light source may not be the optimal solution for asymmetrically distributed disease in human tissue. Depending on the individual patient and the details of the anatomy and tumor, there may be areas within the surgical cavity that will be more likely to contain residual tumor. Focusing light towards these areas to focus the photodynamic therapy (PDT) effect may be beneficial. Clinical trials with intraoperative application of PDT have shown that the input light (fluence, Joules / cm 2 ) and clinical outcomes. In a single application (as part of a longer course of treatment), example devices disclosed herein can deliver customized outputs of light, with greater emphasis / power directed toward areas of greater tumor risk.
[0075] The total amount of light available is limited in implanted devices, primarily due to wireless power transfer limitations and tissue heating limitations, and therefore optimal use of light sources is desirable and can be accomplished in devices that can control the output of multiple lights, such as in a manner that has variable combinations of lights in on-off configurations.
[0076] Furthermore, this configuration can be applied not only to an on vs. off configuration, but also to the control of individual LED light output within a defined range. This can be controlled by firmware embedded in an embedded PCB or housing that will direct the power output of the individual lights within the implant. This control by the user can be accomplished through a user interface designed to control the power delivery and output devices. The planning of this "prescription" for each patient can be similar to the spatial and temporal planning of radiotherapy treatments combined with prescriptive imaging of the tumor location within the patient.
[0077] In Figure 20A, a tether 300 is coupled to a lighting element that includes, in this example, four independently controllable light sources 420, here LEDs. The LEDs are mounted within a substrate 430, such as a flexible PCB, and the assembly may be encapsulated in any manner, as previously described. Because the LEDs may be independently controlled, they may be turned on or off as needed to direct light in a desired direction for a desired amount of time.
[0078] FIG. 20B illustrates the intensity of light emitted by the four LEDs in all four directions as the light is emitted in a direction away from the center of the PCB 430. Each direction has a leaf-shaped pattern that indicates the illumination pattern and emitted light intensity for each LED. As the total power provided by the tether is fixed, the intensity of each LED is higher when only a single LED is activated at a time. Thus, the illumination can be steered in a desired direction and the light intensity can also be controlled.
[0079] (Example of usage)
[0080] FIG. 21 illustrates an example of a method for treating a tumor. Treatment may be determined by a team of physicians and surgeons, which may include a neurosurgeon, a neuroradiologist, and a neuro-oncologist. Any of the illumination devices and optional features disclosed herein may be used according to the following method of use. Although this example is directed to the treatment of brain cancer, it is not intended to be limiting, and one skilled in the art will understand that other diseases and conditions may also be treated.
[0081] MRI (magnetic resonance imaging) scans can be used to determine the size and shape of the tumor, and based on that information, an appropriately sized device can be selected. Other imaging techniques, such as computed tomography (CT), positron emission tomography (PET), radiography, etc., known in the art, can also be used. Illumination doses can also be determined based on the bioavailability of the photosensitizer delivered to the target tissue, and the effective light fluence and timing. In some embodiments, artificial intelligence (AI) or AI classifiers can be employed as pattern recognition tools to at least detect and guide the physician toward an optimized targeted therapy to improve outcomes for the patient. The dose includes the photosensitizer drug dose and frequency, and the light fluence from the implanted phototherapy device. The initial dose can be higher or lower depending on the patient's condition and the expected severity of any remaining tumor cells within the tumor margin.
[0082] A craniotomy, often a 5-10 cm diameter circular section of bone is removed from the skull, allowing access to the patient's brain. After the tumor is resected (2102), the device is implanted (2104) into the tumor cavity formed after the craniotomy and tumor resection surgery, in which the bulk of the glioblastoma tumor or other diseased tissue is removed by a neurosurgeon using standard surgical techniques. The light source portion of the device is fixed in place by the neurosurgeon using methods including any of those known in the art and described herein. The light source may comprise a thin flexible sheet or wallpaper that is glued into the cavity and allowed to harden in place. The surgeon can trim it (2106) to fit the tumor size and shape of the individual patient's tumor.
[0083] The surgeon may adhesively bond or otherwise secure the device into the tumor cavity using cyanoacrylate, fibrin adhesive glue, or similar biocompatible tissue adhesive 2108. The device may be capable of "self-curing" by emitting light of the wavelength required by the adhesive (adhesive glue). An LED emitter may be built into the device or an external curing light may be coupled to a light guide so that the curing light can reach where it is needed. For example, if the adhesive (UV curable adhesive) is cured by light, the light source itself may be its own curing light source. The device may have a fitting connected to a point on the light source and transmit the curing light through the light source to the adhesive (such as the example already described above with respect to FIG. 19).
[0084] If a trimming step is required, the surgeon may trim the light guide shape of the light source to better match the patient's individual tumor cavity with the surgical scissors or other cutting instrument. The light source may include visual markers that indicate areas that should not be cut.
[0085] The implantation of lighting elements is at the discretion of the neurosurgeon, but should ensure that light is directed to regions within the target treatment area that contain residual tumor or are likely to suffer recurrence. For GBM tumors that are arborescent and invasive, an additional margin of up to about 2 cm from the known margin may be a good boundary. For smaller tumors, it may be possible to mount lighting elements so that the entire internal cavity surface is illuminated.
[0086] The device can then be tested (2110) to visually check that the light sources are functional and in the correct place.
[0087] The tether can extend to the outside of the skull, with the wireless power portion of the device secured in place on the outside of the skull and under the scalp anywhere, such as behind the ear. The tether can also be secured to the skull so it cannot be pulled out by the patient. A clip or eyelet can be attached to the skull adjacent to the craniotomy opening, with the tether secured in place using a clip or eyelet, which can also serve to protect the wire from the sharp edges around the craniotomy and hold the tether in place. Excess wire can be coiled around the clip or eyelet. If needed, additional sutures, screws, adhesives, etc. can be used to help secure the tether and coil. A recessed area in the skull can be formed to accommodate the tether, coil, or housing, thereby helping to prevent or minimize bulging. The coil can be placed on the same side as the craniotomy, or it can be placed on the opposite side. Once the device is implanted and secured to the skull, the skull may be closed and the scalp may also be closed.
[0088] Optionally, the illumination system may include radiopaque markers adjacent to the illumination elements to allow a surgeon or physician to visualize and confirm placement of the device within the patient's tumor cavity using imaging techniques known in the art, such as MRI, PET, X-ray, etc.
[0089] After surgical recovery, photodynamic therapy is activated (2112) by powering the wireless power portion of the implant via an external transmitter in the clinic. The implant can control the power level it receives and direct most of that power to the light source. Administration will be monitored by the transmitter under the observation of a human operator. A sufficient dose for effective photodynamic therapy will be required for each session. Since sessions can only be a maximum of a few hours, patients can utilize regular phototherapy sessions and control the recurrence of their tumors over months and even years. One example of a duty cycle includes 1 minute of illumination followed by 30 seconds without illumination, which can then be repeated. This helps to reduce heat and can also allow tissue to re-oxygenate between light cycles. The power receiving element in any embodiment of the device can include a clock oscillator so that it can manage the cycling of the light source. It may be possible for the energy transmitter to reprogram the power receiving element and change the timing of the light delivery.
[0090] Dose fractionation can occur over several days, distinguishing this method from one-time treatments.
[0091] Using the disclosed devices and methods allows for the efficient transfer of significant power to devices while having optical devices in the center of the brain, where traditional wireless power methods cannot easily reach.
[0092] Phototherapy may optionally be combined with imaging and mapping to facilitate directing the illumination. The illumination element may include multiple light sources, allowing steering of light in a desired direction such that if an area is identified as having more tumor cells or is expected to have more tumor cells, phototherapy may be directed in that direction. Phototherapy may also be combined with algorithms and tumor recurrence modeling to steer light to areas of concern with dosages that are also predicted by computer modeling. The devices, systems, and methods described herein may be used with any photosensitizer that provides the desired diagnostic or therapeutic effect. Examples of photosensitizers are described below. The patient is then monitored at regular intervals, e.g., every 3-6 months, for rejection to the photodynamic therapy or photosensitizer drug using brain imaging techniques known in the art to look for tumor recurrence. The patient's dosage and therapy may be adjusted as needed.
[0093] Potential opportunities for individualized treatment may occur at various times during patient therapy, including during resection, during the approximately 6-week recovery period after resection, during the approximately 6-week combination of TMZ (temozolomide) chemotherapy and radiation therapy, and during the 6-month follow-up period.The use of phototherapy may be used alone or in conjunction with any of these periods and treatments to provide improved outcomes.
[0094] (Wavelength of light)
[0095] The wavelength of light delivered by the illumination element is selected based on the wavelength and depth of tissue penetration required to activate the photosensitizer. For example, light within the red to near infrared wavelength range of about 600 nm to 940 nm may have sufficient tissue penetration in brain tissue. This wavelength may be used with any of the example devices disclosed herein.
[0096] (Examples of Photosensitizers)
[0097] Any photosensitizer that can have a therapeutic effect when exposed to light can be used with any of the example lighting systems described herein. Examples of photosensitizers include, but are not limited to, methylaminolevulinic acid hydrochloride, paderiporfin potassium, talaporfin sodium, SGX-301, fimaporfin + gemcitabine, redaporfin, aminolevulinic acid + artemisinin, CTT-1700, IVX-MES, IVX-PDT, IVXP-02, JL-103, photovac, YC-9, ADC + fimaporfin, bleomycin sulfate + fimaporfin, lemuteporfin, methylaminolevulinic acid ... These include: hydrochloride, motexafin lutetium, padoporfin, SL-017, vandiolax, deuteporfin, graft-versus-host disease-targeting ABCB1-activating small molecule, tumor-targeting EGFR-targeting recombinant peptide, eNOS-targeting small molecule, tumor-targeting nNOS and NO synthase, epirubicin hydrochloride plus fimaporfin, porfimer sodium, temoporfin, palladium bacteriophenophorbide, rostaporfin, verteporfin, and 5-aminolevulinic acid.
[0098] These photosensitizers are useful in treating, but are not limited to, basal cell carcinoma (e.g., basal cell epithelioma), squamous cell carcinoma, actinic (e.g., solar) keratosis, skin cancer, solid tumors, prostate cancer, esophageal cancer, transitional cell carcinoma (urothelial cell carcinoma), bile duct cancer (e.g., cholangiocarcinoma), endobronchial cancer, kidney cancer (e.g., renal cell carcinoma), renal cell carcinoma, choroidal neovascularization, brain tumors, gliomas, neurofibromas, head and neck cancer, hepatocellular carcinoma, metastatic colorectal cancer, nasopharyngeal cancer, pancreatic cancer, benign prostatic hyperplasia, and age-related macular degeneration. The light may be used to illuminate in the treatment of a variety of cancers and other diseases, including coronary artery disease, cutaneous vascular malformations, peripheral arterial disease (PAD), peripheral vascular disease (PVD), mycosis fungoides, psoriasis, glioblastoma multiforme (e.g., GBM), inflammatory bowel disease, colorectal cancer, malignant mesothelioma, ovarian cancer, viral infections, colon cancer, graft-versus-host disease (GVHD), carcinoma, sarcoma, acne vulgaris, coronary artery disease (CAD) (e.g., ischemic heart disease), breast cancer, non-small cell lung cancer, small cell lung cancer, and bladder cancer.
[0099] (experiment)
[0100] A sample device was tested having a coil for receiving RF energy, a rectifier for converting the AC current of the received power to DC current, and an LED. The LED emitted light at a wavelength of about 630 nm and had a fluence (energy density) of about 120 J / cm. 2 The radiation power was measured over a range of drive currents from about 0.1 mA to about 20 mA using a photoelectric meter. Based on reported literature, this level of fluence is estimated to have an extrapolated necrotic depth of about 10-20 mm.
[0101] The subject of photosensitizer drug activation is more widely understood in the art. Effective application of photodynamic therapy requires light at an optimal wavelength for photosensitizer (PS) drug activation, at a sufficient intensity, and for a sufficient duration to deliver a minimum light fluence (Joules per square centimeter area).
[0102] When demonstrating efficacy against tumors in preclinical and clinical trials, known experimental protocols use light fluence as a control parameter (i.e., PS activation threshold or target). Thus, for the embodiments of the illumination system disclosed herein to deliver a discrete amount of light fluence consistent with that known in the art, effective activation of PS must ensue. In some embodiments, the target light fluence is between 90 and 500 J / cm. 2 In some embodiments, the target light fluence is between 100 and 200 J / cm 2 It is optimized in
[0103] Fractionated or metronomic PDT (mPDT) has received significant attention in the PDT research community. mPDT can achieve the same dose of PS activation but over a longer period at lower light intensity. Scientific literature has shown that in animal models, <100 uW / cm over a 10 day period. 2reported promising results with an intensity 1,000 times lower than that of typical PDT protocols. By using a much longer duration (1,000 times longer), the product of intensity x time remains constant.
[0104] Other sources use fluence rates (W / cm 2 ) with the same amount of dose, a higher intensity would have an effect indicating that it would kill tumor cells to a greater depth, which may also result in more normal cell killing, supporting the concept of a "threshold" for activation of the photosensitizer.
[0105] Further literature reports that studies using other light fluence rates are possible, ranging from 20 to 400 J / cm. 2 Light fluence rate (100-200J / cm 2 Between 10 and 20 mg / kg / day (and more) have been used, and there is evidence that higher rates may correspond to better outcomes.
[0106] Based on the data contained within these references, implanted phototherapy device therapy is typically 100 J / cm 2 When divided over many hours or even days, the instantaneous power required to deliver this energy is on the order of milliwatts or tens of watts (e.g., 7 mW / cm over a 4 hour period). 2Additional details can be found in Brendan J. Quirk et al., "Photodynamic therapy (PDT) for malignant brain tumors - Where do we stand?" Photodiagnosis and Photodynamic Therapy 12.3 (2015): 530-544, and Tudge, SH et al., Modulation of light delivery in photodynamic therapy of brain tumours, Journal of Clinical Neuroscience, 1999 6(3), 227-232, and Yamagishi, Tissue-adhesive wirelessly powered optoelectronic device for metronomic photodynamic cancer therapy, Nature Biomedical Engineering, January 2019, the entire contents of which are incorporated herein by reference. Notes and Examples
[0107] The following non-limiting examples detail certain aspects of the present subject matter to, inter alia, solve the problems and provide the benefits discussed herein.
[0108] Example 1 is an implantable phototherapy device comprising a receiver element configured to receive power from an external power transmitter, a light delivery element powered by power provided by the receiver and configured to deliver phototherapy to a target treatment area, and a tether element operably coupled to the light delivery element and the receiver element, the tether element configured to deliver power from the receiver element to the light delivery element.
[0109] Example 2 is the device of example 1, wherein the receiver element comprises a coil configured to receive power from an external power transmitter, the power comprising radio frequency energy.
[0110] Example 3 is a device described in any of Examples 1-2, wherein the receiver element comprises a sealed housing operably coupled to the tether, and the device further comprises an electronic component disposed within the sealed housing, the electronic component configured to control the power delivered to the light delivering element.
[0111] Example 4 is a device described in any of Examples 1-3, wherein the light delivery element comprises a light source encapsulated within an optical material configured to protect the light source, and the optical material facilitates the transmission of light from the light delivery element to the target treatment area.
[0112] Example 5 is a device described in any of Examples 1-4, further comprising an optical light guide coupled to the light delivery element, the optical light guide being shaped to facilitate delivery of light from the light delivery element to the target treatment area.
[0113] Example 6 is a device described in any of Examples 1-5, wherein the light delivery element comprises a plurality of light sources arranged on a substrate, and the substrate is configured to be shaped to conform to the target treatment area.
[0114] Example 7 is a device as described in any of Examples 1-6, wherein the substrate is a light guide configured to direct light to a target treatment area, and the substrate is configured to be trimmed to a desired shape to fit the target treatment area.
[0115] Example 8 is a device according to any of Examples 1-7, wherein the light delivering element comprises a plurality of light sources configured to be independently controllable with respect to each other.
[0116] Example 9 is the device of any of Examples 1-8, wherein the light delivery element further comprises a temperature sensor configured to measure a temperature at the target treatment area.
[0117] Example 10 is a device described in any of Examples 1-9, wherein the light delivery element is disposed within a radially expandable member having an expanded configuration and a collapsed configuration, and in the expanded configuration, the radially expandable member conforms to the target treatment area.
[0118] Example 11 is a device described in any of Examples 1-10, wherein the light delivery element further comprises a port configured to releasably receive an optical fiber optically coupled to an external light source, and light from the external light source is delivered to the light delivery element via the optical fiber for illumination of the target treatment area.
[0119] Example 12 is a phototherapy system comprising a device described in any of Examples 1-11, a device described in any of Examples 1-10, and an external power transmitter configured to wirelessly transmit power to a receiver element.
[0120] Example 13 is the device described in Example 12, further comprising a planar immersion lens disposed between the external power transmitter and the receiver element, the planar immersion lens configured to focus energy from the external power transmitter toward the receiver element.
[0121] Example 14 is the system of any of Examples 12-13, further comprising an electrode configured to provide electrical stimulation to the target treatment area.
[0122] Example 15 is the system of any of Examples 12-14, further comprising at least one support element, the support element configured to align with and support tissue in the target treatment area.
[0123] Example 16 is the system of any of Examples 12-15 further comprising a photosensitizer.
[0124] Example 17 is a method of delivering light therapy to a target treatment region within a patient, the method including providing an implantable light therapy device comprising a power receiver element, a light delivery element, and a tether element; implanting the light therapy device within the patient at the target treatment region; wirelessly transmitting power from an external power transmitter to the power receiver element; transmitting power from the power receiver element via the tether to the light delivery element; and illuminating the target treatment area with light from the light delivery element.
[0125] Example 18 is the method of example 17, wherein wirelessly transmitting power from an external power transmitter to the receiver element includes receiving radio frequency energy with a coil.
[0126] Example 19 is the method of any of Examples 17-18, wherein illuminating comprises illuminating the target treatment area with a plurality of light emitting elements that are independently controllable.
[0127] Example 20 is the method of any of Examples 17-19, wherein wirelessly transmitting power includes transmitting power from an external power transmitter and focusing the power toward the receiver element using a planar immersion lens.
[0128] Example 21 is the method of any of Examples 17-20, further comprising electrically stimulating tissue in the target treatment area with energy provided by an electrode adjacent to the light delivery element.
[0129] Example 22 is the method of any of Examples 17-21, wherein the target therapeutic area comprises the brain of the patient.
[0130] Example 23 is a method described in any of Examples 17-22, further comprising releasably coupling an optical fiber to the light delivery element, inputting light from an external light source into the light delivery element via the optical fiber, and illuminating the target tissue using the light from the external light source.
[0131] Example 24 is a method according to any of Examples 17-23, wherein the light delivery element comprises a plurality of light sources disposed on a substrate, and the method further comprises shaping the substrate to conform to the target treatment area, and directing the light in a plurality of directions to illuminate the target treatment area.
[0132] Example 25 is the method of any of Examples 17-24, further comprising trimming the substrate to a desired size or shape to fit the target treatment area.
[0133] Example 26 is the method of any of Examples 17-25, further comprising measuring a temperature in the target treatment area with a temperature sensor.
[0134] Example 27 is a method described in any of Examples 17-26, wherein the light delivery element comprises multiple light sources encapsulated within an optical material, and the optical material is a light guide that directs light from the multiple light sources to the target treatment area.
[0135] Example 28 is the method of any of Examples 17-27, wherein the light delivery element is disposed within a radially expandable member, and the method further includes radially expanding the radially expandable member to align with and conform to the target treatment area.
[0136] Example 29 is the method of any of Examples 17-28, further comprising positioning a support element within the target treatment area to support tissue within the target treatment area and help ensure the tissue is illuminated.
[0137] In Example 30, the device, system, or method of any one or any combination of Examples 1-29 can, optionally, be configured such that all of the elements or options listed are available for use or selection.
[0138] The above detailed embodiments include reference to the accompanying drawings, which form a part of the detailed description. The drawings show, by way of illustration, specific embodiments in which the invention may be practiced. These embodiments are also referred to herein as "examples." Such examples may include elements in addition to those shown or described. However, the inventors also contemplate examples in which only those elements shown or described are provided. Furthermore, the inventors also contemplate examples using any combination or permutation of those elements shown or described (or one or more aspects thereof) with respect to a particular example (or one or more aspects thereof) shown or described herein, or with respect to other examples (or one or more aspects thereof).
[0139] In the event of a conflicting usage between this document and any document so incorporated by reference, the usage in this document shall control.
[0140] The terms "a" or "an" are used herein, as is common in patent documents, to include "one" or "two or more," independent of any other instance or usage of "at least one" or "one or more." The term "or" is used herein to refer to a non-exclusive or, such that "A or B" includes "A but not B," "B but not A," and "A and B," unless otherwise indicated. The terms "including" and "in which" are used herein as the plain English equivalents of the respective terms "comprising" and "wherein." Also, in the following claims, the terms "including" and "comprising" are open-ended, i.e., a system, device, article, composition, formation, or process that includes elements in addition to those recited after such term in a claim, is still considered to be within the scope of that claim. Also, in the following claims, the terms "first," "second," and "third," etc. are used as labeling only and are not intended to impose numerical requirements on their purposes.
[0141] The above description is intended to be illustrative and not restrictive. For example, the above described embodiments (or one or more aspects thereof) may be used in combination with each other. Other embodiments may also be used by those skilled in the art upon review of the above description. The Abstract is provided to enable the reader to quickly ascertain the nature of the present technical disclosure. It should be considered with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. In the above detailed description, various features may be grouped together to simplify the disclosure. This should not be construed as intending that an unclaimed disclosed feature is essential to any claim. Rather, the subject matter of the invention may lie in less than all features of a particular disclosed embodiment. Thus, the following claims are herein incorporated into the detailed description as an example or embodiment, with each claim standing on its own as a separate embodiment, and it is contemplated that such embodiments can be combined with each other in various combinations or permutations. The scope of the present invention should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
Claims
1. 1. An implantable phototherapy device, comprising: a receiver element configured to receive power from an external power transmitter; a light delivery element powered by the power provided by the power receiver element, the light delivery element configured to deliver light to a target treatment area; an optical light guide coupled to the light delivery element, the optical light guide configured to facilitate delivery of light from the light delivery element to the target treatment area, the optical light guide having a spherical central portion having a plurality of spokes extending circumferentially outward from the spherical central portion, a temperature sensor disposed within an encapsulation of the optical light guide, the encapsulation configured to protect the light delivery element and the temperature sensor, the encapsulation having a diffusing or reflective material configured to provide desired optical characteristics of the light delivered from the light delivery element to the target treatment area; a tether element operably coupled to the light delivering element, the receiver element, and the temperature sensor, the tether element configured to deliver the power from the receiver element to the light delivering element and the temperature sensor; A device comprising:
2. The device of claim 1 , wherein the receiver element comprises a coil configured to receive the power from the external power transmitter, the power comprising radio frequency energy.
3. 2. The device of claim 1, wherein the receiver element comprises a sealed housing operably coupled to the tether element, the device further comprising an electronic component disposed within the sealed housing, the electronic component configured to control the power delivered to the light delivering element.
4. The device described in claim 1, wherein the encapsulation portion facilitates transmission of the light from the light delivery element to the target treatment area.
5. 10. The device of claim 1, wherein the light delivery element comprises a plurality of light sources disposed on a substrate, the substrate being configured to be shaped to conform to the target treatment area.
6. 6. The device of claim 5, wherein the substrate is a light guide configured to direct light to the target treatment area, the substrate being configured to be trimmed to a desired shape to fit the target treatment area.
7. The device of claim 1 , wherein the light delivering element comprises a plurality of light sources, the plurality of light sources being configured to be independently controllable with respect to one another.
8. 10. The device of claim 1, wherein the light delivering element is disposed within a radially expandable member having an expanded configuration and a collapsed configuration, wherein in the expanded configuration, the radially expandable member conforms to the target treatment area.
9. 10. The device of claim 1, wherein the light delivering element further comprises a port configured to releasably receive an optical fiber optically coupled to an external light source, wherein light from the external light source is delivered via the optical fiber to the light delivering element for illumination of the target treatment area.
10. 1. A phototherapy system, comprising:
13. An implantable phototherapy device according to claim 1; an external power transmitter configured to wirelessly transmit the power to the receiver element; The system comprises:
11. 11. The system of claim 10, further comprising a planar immersion lens disposed between the external power transmitter and the receiver element, the planar immersion lens configured to focus energy from the external power transmitter towards the receiver element.
12. The system of claim 10 , further comprising an electrode configured to provide electrical stimulation to the target treatment area.
13. 11. The system of claim 10, further comprising at least one support element, the support element configured to align with and support tissue in the target treatment area.
14. The system of claim 10 , further comprising a photosensitizer.
Citation Information
Patent Citations
Apparatus for charging machinery embedded in living body
JP1987102771A
Light guiding device for storage in body
JP1991094776A
Medical treatment device
JP1991094777A
Method and apparatus for performing photoactive therapy
JP1996505803A
Energy transmitting and / Or information transmitting system to device for implantation into body
JP2000079170A
